Results 201 to 210 of about 6,153 (216)

Senolytics Decrease Senescent Cells in Humans: Preliminary Report From a Clinical Trial of Dasatinib Plus Quercetin in Individuals With Diabetic Kidney Disease

EBioMedicine, 2019
Michael D Jensen, Shane A Bobart, Joao F Passos   +2 more
exaly  

Senolytics in Idiopathic Pulmonary Fibrosis: Results From a First-in-Human, Open-Label, Pilot Study

EBioMedicine, 2019
Nathan K. LeBrasseur, Michal M Masternak
exaly  

Fisetin: A senolytic drug

2021
Asma Shafique, Sumia Akram, Muhammad Mushtaq   +2 more
openaire   +1 more source

Senolytics

Abhilasha Ahlawat, Neeta Solanki, Sachin Kumar Singh, Kamal Dua, Harish Dureja   +4 more
openaire   +1 more source

Senolytic compositions and uses thereof

2021
GALLOP MARK A, QUARTA MARCO, KLEIN JULIAN   +2 more
openaire   +2 more sources

SENOLYTIC COMPOUNDS

2018
GIL JESUS, GUERRERO ANA, HARRANZ NICOLAS
openaire   +3 more sources

Current Senolytics: Mode of Action, Efficacy and Limitations, and Their Future

Mechanisms of Ageing and Development
Johannes Grillari
exaly  

Quercetin and Dasatinib, Two Powerful Senolytics in Age-Related Cardiovascular Disease

Biogerontology
Mina Königsberg, Alejandro Silva-Palacios, Mario Nieto   +2 more
exaly  

Adding to the senolytic arsenal

Nature Reviews Drug Discovery, 2019
openaire   +1 more source

Senolytics Target Cellular Senescence — But Can They Slow Aging?

Nature Medicine
Natalie Healey
exaly